V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290004548 | 290003337 | null | 90 | Disease modification (D) | 2016-02-13 | 2016-02-13 | Fluorouracil 96hr infusion+R(4g/m2) | 02 | N | 290021387 | CARBOPLATIN |
| 290004549 | 290003337 | 1.64 | 67.65 | null | 2016-01-03 | 2016-01-17 | CARBOPLATIN + RT | null | null | 290021387 | FLUOROURACIL |
| 290004550 | 290008186 | 1.6 | 66.4 | Palliative (P) | 2017-02-21 | 2017-02-21 | Bevacizumab 5mg/kg | 02 | N | 290021391 | CISPLATIN + FLUOROURACIL |
| 290004551 | 290008186 | 1.48 | 59.4 | Curative (C) | 2013-07-29 | 2013-08-25 | LANREOTIDE | N | Y | 290021391 | IBRUTINIB |
| 290004552 | 290003338 | 1.82 | 67.4 | Curative (C) | 2015-01-14 | 2015-02-03 | Cisplatin + Docetaxel +Fluorouracil | N | Y | 290021396 | CISPLATIN + FLUOROURACIL |
| 290004553 | 290006506 | 1.81 | 63.4 | null | 2017-07-28 | 2017-08-13 | CISPLATIN + FLUOROURACIL | N | N | 290021397 | CAPECITABINE + CISPLATIN |
| 290004554 | 290003339 | null | 89.6 | Adjuvant (A) | 2017-09-16 | 2017-09-27 | Y-90 | N | N | 290021398 | CAPECITABINE |
| 290004555 | 290003340 | 1.8 | 83.5 | Palliative (P) | 2017-01-06 | 2017-01-07 | Cisplatin +Fluorouracil (3 wk) | N | N | 290021399 | CAPECITABINE |
| 290004556 | 290003340 | 1.87 | 65 | Neo-adjuvant (N) | 2015-12-13 | 2015-12-16 | LANREOTIDE | 02 | N | 290021399 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 290004557 | 290003341 | 1.5 | 55.2 | Curative (C) | 2014-10-24 | 2014-11-18 | Trial Unspecified | N | Y | 290021403 | CAPECITABINE |
| 290004558 | 290003342 | 1.64 | 65.2 | Palliative (P) | 2016-01-23 | 2016-02-18 | LANREOTIDE | null | N | 290021405 | FLUOROURACIL |
| 290004559 | 290003343 | 1.6 | 81 | Curative (C) | 2016-12-12 | 2017-01-05 | LANREOTIDE | 02 | Y | 290021406 | CARBOPLATIN + ETOPOSIDE |
| 290004560 | 290003344 | 1.61 | 69 | Disease modification (D) | 2014-01-06 | 2014-06-22 | Cisplatin +Fluorouracil (3 wk) | N | N | 290021409 | CAPECITABINE |
| 290004561 | 290003345 | 1.58 | 53.6 | Palliative (P) | 2016-11-14 | 2016-11-28 | LANREOTIDE | N | N | 290021410 | PEMBROLIZUMAB |
| 290004562 | 290003346 | 1.68 | 58.05 | Palliative (P) | 2014-04-05 | 2014-04-05 | Capecitabine + Streptozocin | null | N | 290021411 | LANREOTIDE |
| 290004563 | 290003346 | 1.85 | 84.4 | Adjuvant (A) | 2015-11-28 | 2015-11-28 | CARBOPLATIN + FLUOROURACIL | N | N | 290021411 | CARBOPLATIN + ETOPOSIDE |
| 290004564 | 290003346 | 1.72 | 162.5 | Palliative (P) | 2016-08-11 | 2016-09-14 | Gemcitabine + Capecitabine | N | N | 290021411 | CARBOPLATIN + PACLITAXEL |
| 290004565 | 290008187 | 1.59 | 51.3 | null | 2015-09-14 | 2015-09-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 290021415 | CHOP |
| 290004566 | 290003347 | 1.6 | 36 | Adjuvant (A) | 2018-03-26 | 2018-04-13 | CARBOPLATIN + FLUOROURACIL | N | Y | 290021416 | CISPLATIN + FLUOROURACIL |
| 290004567 | 290003348 | 1.69 | 86.5 | Adjuvant (A) | null | 2013-11-15 | OCTREOTIDE | N | N | 290021418 | CISPLATIN + FLUOROURACIL |
| 290004568 | 290003348 | 1.75 | 88 | Neo-adjuvant (N) | 2013-07-19 | 2013-07-22 | ECX | 02 | N | 290021418 | CAPECITABINE + CISPLATIN |
| 290004569 | 290003349 | 1.78 | null | Curative (C) | null | 2015-09-18 | Carboplatin AUC 2 - 5 | null | N | 290021424 | FLUOROURACIL |
| 290004570 | 290003350 | 1.59 | null | Palliative (P) | null | 2014-10-06 | Capecitabine 35days + RT | null | null | 290021425 | EOX |
| 290004571 | 290003351 | 1.54 | 66.3 | Not known (9) | 2015-07-18 | 2015-08-21 | Cisplatin + Pemetrexed | 02 | null | 290021426 | CARBOPLATIN + ETOPOSIDE |
| 290004572 | 290003352 | 1.51 | 106 | Adjuvant (A) | 2013-04-30 | 2013-04-30 | GEMCITABINE | N | N | 290021427 | CETUXIMAB + CISPLATIN + FU |
| 290004573 | 290003353 | 1.7 | 0 | Neo-adjuvant (N) | 2014-04-19 | 2014-04-28 | OCTREOTIDE | 2 | N | 290021430 | FLUOROURACIL |
| 290004574 | 290003354 | 1.76 | null | Not known (9) | 2016-04-24 | 2016-04-25 | LANREOTIDE | N | N | 290021432 | CAPECITABINE |
| 290004575 | 290006510 | 1.64 | 66 | Adjuvant (A) | null | 2016-12-17 | Capecitabine | null | null | 290021433 | LANREOTIDE |
| 290004576 | 290003355 | 1.62 | null | Curative (C) | null | 2016-11-23 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290021434 | CAPECITABINE + RT |
| 290004577 | 290003356 | null | null | Curative (C) | 2014-01-18 | 2014-02-09 | Cisplatin + Docetaxel +Fluorouracil | 02 | Y | 290021435 | CETUXIMAB + OXALIPLATIN + MDG |
| 290004578 | 290003357 | null | 0 | Palliative (P) | 2018-04-07 | 2018-04-13 | Capecitabine + Cisplatin | 02 | N | 290021437 | CISPLATIN + FLUOROURACIL |
| 290004579 | 290006511 | null | 39.5 | Palliative (P) | 2017-10-01 | 2017-10-14 | Capecitabine 42days + RT | 02 | N | 290021439 | ETOPOSIDE |
| 290004580 | 290003358 | 1.87 | 72 | Neo-adjuvant (N) | 2014-03-15 | 2014-03-15 | Capecitabine 35days + RT | 01 | N | 290021440 | CARBO + FLUOROURACIL |
| 290004581 | 290003359 | 1.83 | 73 | null | 2012-11-06 | 2013-10-17 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | N | 290021441 | LANREOTIDE |
| 290004582 | 290003360 | null | 71.3 | Palliative (P) | 2015-01-26 | 2015-02-22 | Carboplatin + Etoposide iv&po | 2 | null | 290021442 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004583 | 290003361 | 1.55 | 53.6 | Adjuvant (A) | 2015-05-17 | 2015-06-03 | ECX | N | N | 290021443 | CAPECITABINE + STREPTOZOCIN |
| 290004584 | 290003362 | 1.83 | 81 | Curative (C) | 2016-02-05 | 2016-02-05 | RCEOP | N | N | 290021444 | CISPLATIN + FLUOROURACIL |
| 290004585 | 290006512 | 1.65 | 70 | Palliative (P) | 2015-03-27 | 2015-04-17 | Capecitabine 35days + RT | 02 | N | 290021449 | CAPECITABINE |
| 290004586 | 290003363 | null | 56.15 | Curative (C) | 2016-11-27 | 2016-11-28 | MITOMYCIN | N | N | 290021450 | CISPLATIN + VINORELBINE |
| 290004587 | 290003364 | 1.57 | 51.1 | Adjuvant (A) | 2015-08-13 | 2015-08-17 | EOX | 02 | N | 290021451 | OCTREOTIDE |
| 290004588 | 290003364 | null | null | Adjuvant (A) | 2014-04-24 | 2014-05-21 | Capecitabine | N | N | 290021451 | CETUXIMAB |
| 290004589 | 290003364 | 1.74 | 86.3 | Palliative (P) | 2017-06-15 | 2017-07-05 | Carboplatin AUC 6 - 10 | 02 | null | 290021451 | CARBOPLATIN + PEMETREXED |
| 290004590 | 290003364 | 1.6 | 93 | Neo-adjuvant (N) | 2013-07-24 | 2013-08-15 | CARBOPLATIN + RT | N | N | 290021451 | CAPECITABINE + RT |
| 290004591 | 290003365 | 1.84 | 67.7 | Neo-adjuvant (N) | 2014-11-21 | 2014-11-21 | Capecitabine + Streptozocin | 02 | N | 290021460 | LANREOTIDE |
| 290004592 | 290003365 | 1.72 | 57.5 | Neo-adjuvant (N) | 2016-12-25 | 2016-12-25 | Capecitabine | N | N | 290021460 | OCTREOTIDE |
| 290004593 | 290003366 | 1.74 | 110.7 | Curative (C) | 2014-07-16 | 2014-08-06 | LANREOTIDE | 02 | null | 290021462 | FLUOROURACIL |
| 290004594 | 290003367 | 1.7 | 67 | Palliative (P) | 2018-06-12 | 2018-06-16 | FLUOROURACIL + IRINOTECAN | N | N | 290021464 | CAPECITABINE |
| 290004595 | 290003368 | 1.48 | 0 | Curative (C) | 2013-06-23 | 2013-06-23 | Fluorouracil 96hr infusion+R(4g/m2) | 02 | Y | 290021466 | CARBOPLATIN + ETOPOSIDE |
| 290004596 | 290003368 | null | 50.75 | Palliative (P) | null | 2018-05-09 | Irinotecan | N | N | 290021466 | LANREOTIDE |
| 290004597 | 290003368 | null | 68.2 | null | 2015-01-11 | 2015-01-11 | LANREOTIDE | N | N | 290021466 | Y-90 |